Friday, November 15th, 2019
Roche Diagnostics North American Corporate Headquarters
9115 Hague Road, Indianapolis, IN
Personalized/precision medicine, genomics, immunotherapy, and regenerative medicine are all approaches either under development or already being used separately in combination to treat cancer. Speakers and panelists will provide the latest therapies, their business implications and Indiana’s Contribution to and role in their development.
Keynote Presentation – (Broad View of Cancer Treatment Efforts)
Phil Low, PhD, Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry–Biochemistry, Purdue University
Panel- Recent Advancements in Oncology: Innovative Treatments and Strategies
Moderator: Vincent Drouillon, PharmD, Clinical Biologist, Vice President, Global Testing Services, Global Testing Services, Covance
Panel Members:
- Clinical Trials – Steven Anderson, PhD, Chief Science Officer, Covance
- Precision Medicine/Genomics – Milan Radovich, PhD, Prof. IU School of Medicine, IU Health Vice President for Oncology Genomics, Co-Director IUH Precision Genomics
- Diagnostics – Ketan Paranjape, Vice President of Diagnostics Information Solutions,Roche Diagnostics
- Pharmaceutical – Symantha Melemed PhD, Global Product Team and Novel Target Leader, Oncology, Eli Lilly and Company
Break for Lunch
Introduction: Jeff Weber, Senior Director: Corporate Affairs – Immunology at Eli Lilly and Company
Luncheon Keynote – (Societal/Economic Impact of Improved Outcomes) Bryan Loy, MD, Physician Lead- Oncology, Laboratory, and Personalized Medicine, Humana
Panel-The Future of Oncology – Great Promise, Significant Challenges
Moderator: Jeffrey Solzak, Director of Translational Oncology, IU School of Medicine
Panel Members:
- Clinical Trials – Steven Anderson, PhD, Chief Science Officer, Covance
- Precision Medicine/Genomics – Milan Radovich, PhD, Prof. IU School of Medicine, IU Health Vice President for Oncology Genomics, Co-Director IUH Precision Genomics
- Diagnostics – Ketan Paranjape, Vice President of Diagnostics Information Solutions, Roche Diagnostics
- Pharmaceutical – Symantha Melemed PhD, Global Product Team and Novel Target Leader, Oncology, Eli Lilly and Company
Leave a Reply